Clinical Trial Update: The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating OK-101 for efficacy and safety in dry eye disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OK-101

Snippet

Sponsor: Okyo Pharma Ltd | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED